HIGHLIGHTS
- who: Yue Ma et al. from the Luigi Vanvitelli, Italy University, China have published the article: Comparative efficacy and toxicity of immune checkpoint inhibitors in combination with or without chemotherapy treatment for advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis, in the Journal: (JOURNAL)
- what: The study shows that among second-line treatments, ICIs combined with chemotherapy in the treatment of esophageal squamous cell carcinoma had statistically significant OS, 12-month overall survival (12 OS), treatment-related adverse reactions, treatment-related grade 3 or more adverse reactions, objective response rate (ORR), and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.